Last updated: 2026-09-09 09:50:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Eton Pharmaceutcials, Inc. (ETON) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $59.14, with a market capitalization of $1.67B and a P/E ratio of 133.70. Over the past 52 weeks, its price has ranged from $14.27 to $66.37. This page covers its latest market performance, valuation, price trends and company information.
$1.67B | |
$58.23 | |
$66.37 | |
$1.95 | |
$59.35 | |
208.00 | |
547.93K | |
133.70 | |
$66.37 | |
$14.27 | |
-- | |
-- |
Eton Pharmaceutcials, Inc. (ETON) is trading at $59.14 in pre-market trading as of 2026-09-09 09:18:00, down 0.35% ($0.21) from the previous close of $59.35
Pre-market trading shows how investors are pricing ETON before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Eton Pharmaceutcials, Inc. (ETON) moved from $59.78 to $59.14, representing a decline of 1.08% ($0.65).
The stock traded between $56.11 and $62.91 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 559.23 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 86.1%
ETON is currently trading at $59.14, placing it 86.1% of the way from its 52-week low of $14.27 to its 52-week high of $66.37. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 44 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Eton Pharmaceutcials, Inc. (ETON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.